Cyclophosphamide Split in Two Blocks Apart Renders an Excellent Cardiac Safety Profile during Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis and Other Autoimmune Disorders

MLA

Juan Carlos Olivares-Gazca, et al. “Cyclophosphamide Split in Two Blocks Apart Renders an Excellent Cardiac Safety Profile during Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis and Other Autoimmune Disorders.” Transplantation and Cellular Therapy, vol. 28, Mar. 2022, pp. S236–37. EBSCOhost, https://doi.org/10.1016/s2666-6367(22)00462-6.

APA

Juan Carlos Olivares-Gazca, Francisco Guerrero-Pesqueira, Iván Murrieta-Álvarez, Yahveth Cantero-Fortiz, Andrés Leon-Peña, Manuel Priesca-Marin, David Gómez-Almaguer, Andrés Gómez-De-León, Guillermo J. Ruiz-Delgado, & Guillermo J. Ruiz-Argüelles. (2022). Cyclophosphamide Split in Two Blocks Apart Renders an Excellent Cardiac Safety Profile during Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis and Other Autoimmune Disorders. Transplantation and Cellular Therapy, 28, S236–S237. https://doi.org/10.1016/s2666-6367(22)00462-6

Chicago

Juan Carlos Olivares-Gazca, Francisco Guerrero-Pesqueira, Iván Murrieta-Álvarez, Yahveth Cantero-Fortiz, Andrés Leon-Peña, Manuel Priesca-Marin, David Gómez-Almaguer, Andrés Gómez-De-León, Guillermo J. Ruiz-Delgado, and Guillermo J. Ruiz-Argüelles. 2022. “Cyclophosphamide Split in Two Blocks Apart Renders an Excellent Cardiac Safety Profile during Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis and Other Autoimmune Disorders.” Transplantation and Cellular Therapy 28 (March): S236–37. doi:10.1016/s2666-6367(22)00462-6.